#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury cervical Sjogren's syndrome Nephrotic syndrome Hidradenitis Juvenile idiopathic arthritis Fms-like tyrosine kinase 3 positive Cardiac sarcoidosis Mantle cell lymphoma stage IV Hodgkin's disease recurrent Glomerulonephritis membranoproliferative Haemophilia B without inhibitors Orthostatic hypotension Hepatitis B Subdural haematoma Acute leukaemia More trials…

    Learn about Rare Diseases

    MELAS syndrome – Life with Disease Cholangitis sclerosing – Trials in Disease Haemolytic uraemic syndrome – Basic Information Erdheim-Chester disease – Life with Disease Stevens-Johnson syndrome – Life with Disease Mucopolysaccharidosis I – Life with Disease Alagille syndrome – Diagnostics Familial amyotrophic lateral sclerosis Rhabdomyosarcoma recurrent Alexander disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ziclumeran Pabinafusp Alfa Oleclumab Vimseltinib Ep0042 Potassium Iodide Diroximel Fumarate Ponatinib Nvdx3 Sugammadex Quercus Ilex Allergen Extract Taminadenant Gs-4182 Vanglusagene Ensiparvovec Holcus Lanatus Pollen Extract Fadraciclib Adagrasib Clascoterone Ursodeoxycholic Acid Midomafetamine Hydrochloride More therapies…

    Learn about Your Condition

    Skin candida Uveal melanoma Neoplasm malignant Perinatal depression Mesothelioma Arrhythmia Dilated cardiomyopathy Oesophagogastroscopy Senile dementia Haemophilia Abdominal pain Iron deficiency Acoustic neuroma Myelodysplastic syndrome Pleural mesothelioma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on JNJ-64042056 for Preclinical Alzheimer’s Disease in Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Jnj-64042056
    Belgium France Germany Spain Sweden

  • Study on the Effects of Ketamine and Electroconvulsive Therapy in Patients with Treatment-Resistant Major Depressive Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy

  • Study on Pioglitazone for Adults with Non-Segmental Vitiligo

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Pioglitazone
    Italy

  • Study on Immediate vs. Delayed Insertion of Levonorgestrel IUD for Women After Medical Abortion

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Levonorgestrel
    Sweden

  • Study on the Use of 68Ga-EVG321 for Diagnosing Small Cell Lung Cancer in Patients

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Evg321
    • Gallium (68Ga)
    Austria Germany Italy

  • Study on Irinotecan and mFOLFOX4-Bevacizumab for Patients with Resectable Colorectal Peritoneal Metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    The Netherlands
Previous Page
1 … 900 901 902 903 904 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!